Invitation  


Tata Memorial Centre
Cordially invites you to the
6th conference on
“Evidence Based Management of Cancers in India”
to be held from the 29th Feb -2nd March 2008

This three day meeting will coincide with the “Hospital Day Celebrations” on 29th Feb, 2008. In the past five years our meetings have focused on Evidence based guidelines for treatment of common cancers in India. This year we focus on Central Nervous Tumours, role of Molecular Diagnostics and Interventional Radiology in oncology practice. The invited faculties (national and international) are an authority with significant contribution to current world literature. The meet is focused at all oncology professionals in general and specifically those involved in the above these topics including surgical oncologists, radiation oncologists, medical oncologists, paediatric oncologists, neurosurgeons, radiologists, pathologists, basic scientists, support groups and all postgraduate students of the these specialties. Everyone is requested to register for the conference as early as possible. Limited registration is also available in the area of ones interest. A 'management guidelines book' on the current evidence on these topics will also be released during this meeting for all delegated as well as all interested professionals round the country.

Patron
DR K A DINSHAW
Director, Tata Memorial Centre

Organising Secretaries
Dr Rakesh Jalali NeuroOncology
Dr Sangeeta Desai Molecular Diagnostics
Dr Suyash Kulkarni Interventional Radiology

 
Top
 
 

Faculty

 
 

 

 
   

CNS Tumours

Prof Minesh Mehta
University of Wisconsin, USA

Prof Abhijit Guha
University of Toronto, Canada


Dr M Vogelbaum
Cleveland Clinic, Ohio, USA


Dr A Mahajan
MD Anderson Cancer Centre, USA

Dr Anjan Misra
Barrow Neurological Institute, USA


Molecular Diagnostics In Oncology

Prof Arul Chinnaiyan
Michigan Centre for Translational Pathology
Ann Arbor, USA


Dr Sankarnarayanan
IARC, Lyon, France

Interventional Radiology in Oncology

Prof K J Murphy
John Hopkins Medical Institute, USA


Prof R Salem
Northwestern Memorial Hospital, USA

Dr David Madoff
M D Anderson Cancer Hospital, USA

Dr F Deschamps
Institut Gustave Roussay, France


In addition to the above, a number of eminent and well known experts at the national level in the above fields will participate as Guest faculty.

 
   
Top
 
 

Programme

 
   

Programme Highlights

CNS Tumours
29th Feb-1st March, (Fri, Sat) 2008 (2 days)

  • Epidemiology and demographic profile of CNS tumours in India
  • Imaging in management of CNS tumours and role of emerging techniques
  • Role of biopsy, decompression and radical surgery in high grade tumours.
  • Surgical technique and evidences in the management of benign CNS tumours.
  • Conformal radiotherapy, Intensity modulated Radiotherapy, Stereotactic, radiotherapy and tomotherapy in CNS tumours
  • Evidences and rationale for use of chemotherapy in gliomas and pediatric tumours.
  • Targeted therapies in CNS tumours
  • Quality of life issues in CNS tumour
  • Craniofacial surgery

Molecular Diagnostics
1st March 2008, (Saturday) (1 day)


Diagnostic,  prognostic & therapeutic implications in various subspecialities of  surgical oncopathology 

Interventional Radiology  
2nd March 2008, (Sunday) (1 day)
( Workshop ½ day on 29th Feb / 1st March 2008)

  • Minimally invasive therapies for primary and secondary tumours of the liver.
  • Thermal ablation with Radiofrequency
  • Transarterial Chemotherapy and Chemoembolization
  • Hepatic artery ports.
  • Under standing liver regeneration  Portal vein embolisation.
  • Emerging therapies with liver tumours  tumour boards and multidisciplinary management.
  • Management of primary and secondary neoplasm of the lung with radiofrequency ablation

 
 
CNS Tumours
29th Feb-1st March
 
   

CNS tumours, though uncommon are not a rare entity in clinical practice. These tumours are quite diverse in neurosurgical and neurooncological practice ranging from benign to malignant tumours and affecting practically all age groups right from the very young to the very old. Management of these tumours also poses several challenges from the therapeutic modalities to ancillary care including rehabilitation and support services. There is a tremendous amount of focus in basic, molecular and clinical research in these tumours. There are several ongoing prospective and randomized clinical trials in different parts of the world addressing wide range of management issues of these tumours. Several newer surgical innovations, chemotherapeutic agents and radiation therapy delivery techniques are being studied with emerging evidences, which mandates a critical appraisal of current evidences in the management of such tumours.  One of the primary aims of the proposed conference would be to sift the evidence critically, particularly to address its applicability in the Indian scenario. In addition, we will attempt to set the tone and a dialogue for possibly conducting suitable multicentric studies in our patient populations and set up.  The conference will hopefully be an appropriate platform for all professionals involved in the care and research of patients with CNS tumours to evolve management guidelines as per the best available evidence appropriate for our country and laying future directions as well.

Highlights

  • Guideline for management of common CNS tumours.
  • Diagnostics including recent innovations in Imaging, Pathologyand Molecular biology of CNS tumours.
  • Glioma management including the role of Surgery, Radiotherapy.
  • Chemotherapy and emerging role of Targeted therapies.
  • Future prospect of high precision radiotherapy techniques in CNS tumours.
  • Quality of life (QOL) issues.
  • NeuroOncology Society
 
   
Top
 
 

Molecular Diagnostics in Oncology
1st March 2008

 
   

The growing momentum of molecular analysis has enormouspromisefor diagnostics and numerous research applications.  The vast arsenal of newer modalities in the field of molecular pathology available today is bewildering and ever expanding. They provide opportunities tostudy etiopathogenesis, to aid diagnosis, to prognosticate and to devise targete therapy in cancer. The challenge for molecular diagnostics is to provide valuable molecular information for tumours using reproducible, cost-effective, and time-efficient assays that can be integrated into the current framework of specimen processing in anatomic pathology. Evidence based molecular diagnostics is the need of the hour. The theme of the conference is integration of diagnostic skills and best available, appropriate “molecular” evidence which would help in decision making and clinical management.  This EBM conference at Tata Memorial Hospital will be the first of its kind to address the focused question of “Molecular Diagnostics for the Clinic” and will hopefully go a long way in rendering insights into integrating molecular methodology into routine diagnostic laboratories.

Highlights

  • Diagnostic, prognostic & therapeutic implications in routine surgical oncopathology
  • The impact of molecular markers in oncology practice especially in Paediatric / Round cell tumours, Haematolymphoid malignancies, Soft tissue tumours, breast, GIT,  CNS and lung tumours
 
   
Top
 
 

Interventional Radiology
2nd  March 2008

 
   

The technical developments in imaging and interventions are advancing at a rapid pace. Today's Interventional Radiology is an ntegral part of the multidisciplinary team with essential functions in every aspect of patient care including diagnosis, minimally invasive therapy, management of treatment related complications, surveillance and palliation of cancer related end of life symptoms and pain. This increasing role of Interventional Radiology in the management of cancer has given birth to the new branch of medicine, called Interventional Oncology and over last two decades it has matured to a specialty. The theme of the conference is to provide guidelines on the basis of world wide experience and clinical research focused on Image guided Interventional Oncology therapies and their relationship to other existing and emerging treatments. The meeting will include presentations of clinical research delivered and debated by some of the most eminent world's experts in Interventional Radiology; in a forum that promotes meaningful discussion among experts in all the oncology therapy disciplines. There will be open and panel discussion on available and emerging therapies and the current evidence

Highlights

  • Live case demonstrations of Interactive workshop on
    • RadioembolizationPortal Vein Embolization
    • RF Ablation
    Vertebroplasty & Cementoplasty for skeletal metastases. Venous thromboembolism and CVST current management issues.
  • Panel discussion on retrievable filters

 
   
Top
 
 

Poster

 
   

Poster abstracts submission guidelines

Instructions


We have provision for a limited number of abstracts, especially from interested delegates and postgraduate students to attend this meeting. You are therefore invited to submit scientific poster
abstracts in relation to the conference topics (CNS Tumours, Molecular diagnostics in Oncology and Interventional Radiology)

Poster submission guideline

  • Abstracts must be in English and should not exceed 300 words (Arial Front, Size 11).
  • Abstracts may be submitted by e-mail to tmhebm@tmcmail.org or by post to the secretariat (address in the registration form) before 10th February 2008.
  • Abstract should be structured as Purpose, Material & Methods, Results and Conclusion
  • The confirmation of acceptance by the Scientific Committee will be communicated to the Presenting Author by e-mail.
  • Registration is mandatory for all participants, including those who are presenting.
  • One Participant can present one abstracts only.
  • Deadline: 10th February 2008.

  • All selected abstracts will be presented as POSTER PRESENTATIONS.
  • Size of poster: 100 cm x 100 cm.
  • Abstracts should be carefully checked for errors and misspellings before submission.
  • Abstracts must be in English. Title should be in capital letters
  • Poster will be displayed from 9.00 a.m to 5.00 p.m. from 29th February 2008 onwards.
  • Poster should be organized under the headlines Title, Introduction, Materials and Methods, Results and Conclusion.
  • There will be a separate poster discussion session where the presenters of selected posters may be asked to make a brief presentation of 3 minutes in MS Power Point.
  • The selection of accepted abstracts for poster presentation will be made by the international scientific committee and  authors will be informed latest by 15th January  2008.
 
   
Top
 
 

General Information

 
   

MUMBAI

 
   

Mumbai is India’s largest city and is also its commercial capital, industrial powerhouse, busiest port, fashion capital, home to ‘Bollywood’(India’s Hollywood), world’s biggest textile market. Mumbai pulsates with  activity and it thrives on contrasts- the city is home to the richest and the poorest of Indians, sleek limousines jostle rusty cycles, red double-decker buses rumble past three-wheeler auto-rickshaws; impressive high rises soar  above crowded slums and shanty towns; glitzy shop fronts amid pavement stalls; glamorous film stars and beggars demand attention at traffic  lights and amidst all this are people, everywhere,  for Mumbai is home to some Mumbai is a cluster of Seven Islands and derived its name from Mumbadevi,  the patron goddess of the koli fisher folk, its oldest inhabitants. Like a giant  magnet, Mumbai draws people from all walks of life traders and artisans, musicians and movie stars, peasants & industrialists entrepreneurs and executives, students and dropouts. In fact, any Indian with a dream head for Mumbai and this pulsating, cosmopolitan, multi-cultural city of opportunity  holds them all to its bosom. Mumbai is like little bites of India all role into one sprawling city stay a while in Mumbai, the most happening city in this part of the world. Expore its sights and soul the promise of a heady experience  awaits you. Dazzling shopping arcades, exciting sport activites, night clubs & discotheques, theatre & music gourmet, restaurants and interesting  sightseeing places. It is a city that is disciplined by no time frame neither day  nor night. Mumbai offers visitors a heady mix of all this and more.

 
   
Top
 
 

Contact Us

 
    For Further Detail : Please contact  
   

Ms. Bindu A.
Clinical Research Secretariat
Room No.6-13, 3rd Floor, Main Block,
Tata Memorial Hospital,
Parel, Mumbai - 400 012 , India.
Phone : +91-22-2417 7000, Extn : 4254 & 4259, 7159
Fax : +91-22-2415 4005
E-mail : tmhebm@tmcmail.org
Web sites : http://tmc.gov.in
www.braintumourindia.com